Product
Insuline glargine U100
1 clinical trial
3 indications
Indication
Diabetes MellitusIndication
Type 2Indication
ObesityClinical trial
Efficacy and Safety of Once-weekly Semaglutide S.C. 2.0 mg as Add-on to Dose-reduced Insulin Glargine vs Titrated Insulin Glargine in Participants With Type 2 Diabetes and OverweightStatus: Recruiting, Estimated PCD: 2025-05-21